Article summary
Real-world data confirms the extremely low physical risk of psychedelics; the NHS and FDA intensify their scrutiny of clinical rollout; and we see expanding legal momentum in the US, as well as a shift towards shorter-acting compounds and β¦ The post PSYCH NEWS β 26/01/2026 appeared first on Chemical Collective.
Continue to the original publication for the complete article.